Researchers Discover New Type of Mycovirus
News Aug 03, 2015
Researchers, led by Dr Robert Coutts, Leverhulme Research Fellow from the School of Life and Medical Sciences at the University of Hertfordshire, and Dr Ioly Kotta-Loizou, Research Associate at Imperial College, have discovered a completely novel type of mycovirus.
The virus infects the fungus Aspergillus fumigatus, which can cause the human disease aspergillosis. This fungal infection targets the lungs and represents a major cause of morbidity and mortality in immunocompromised individuals.
The mycovirus called Aspergillus fumigatus tetramycovirus-1 (AfuTmV-1) is comprised of four strands of double-stranded ribonucleic acid (dsRNA) and possesses unique sequence features and genomic organisation. Unlike nearly all viruses its genetic information is not encapsidated but coated in a virus encoded protein and these ribonucleoprotein structures were visualised for the first time using atomic force microscopy.
Most importantly, the genome of AfuTmV-1 can infect the fungus on its own, without a protein capsid, a feature which has never been shown previously for a dsRNA containing virus. Therefore, the genome can potentially be altered through genetic engineering and directly introduced into the fungus.
It is hoped that AfuTmV-1 might eventually be used to develop a silencing vector, a tool to switch off fungal genes, in order to study what in Aspergillus fumigatus can cause aspergillosis in humans.
AfuTmV-1 is the prototype of a new mycovirus family but is not unique since similar mycoviruses have also been discovered in different fungal genera suggesting potential utility of these dsRNA elements for constructing generic silencing vectors for fungi in the future.
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.
Possible Biomarker to Identify Who Would Benefit from ImmunotherapyNews
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.READ MORE
Fight Against Cancer: Drug Combination Helps Kickstart the Immune SystemNews
Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.
The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialled as a treatment for neonatal jaundice, that together help kick start the body's natural defences.